Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 30;1(4):513-26.
doi: 10.3390/vaccines1040513.

What Has 30 Years of HIV Vaccine Research Taught Us?

José Esparza  1
Affiliations

What Has 30 Years of HIV Vaccine Research Taught Us?

José Esparza. Vaccines (Basel). .

Abstract

When HIV was discovered and established as the cause of AIDS in 1983-1984, many people believed that a vaccine would be rapidly developed. However, 30 years have passed and we are still struggling to develop an elusive vaccine. In trying to achieve that goal, different scientific paradigms have been explored. Although major progress has been made in understanding the scientific basis for HIV vaccine development, efficacy trials have been critical in moving the field forward. Major lessons learned are: the development of an HIV vaccine is an extremely difficult challenge; the temptation of just following the fashion should be avoided; clinical trials are critical, especially large-scale efficacy trials; HIV vaccine research will require long-term commitment; and sustainable collaborations are needed to accelerate the development of an HIV vaccine. Concrete actions must be implemented with the sense of urgency imposed by the severity of the AIDS epidemic.

Keywords: AIDS; HIV; HIV vaccines; clinical trials; lessons learned.

PubMed Disclaimer

References

    1. Gallo R.C., Montagnier L. The chronology of AIDS research. Nature. 1987;326:435–436. - PubMed
    1. Esparza J. A brief history of the global effort to develop a preventive HIV vaccine. Vaccine. 2013;31:3502–3518. doi: 10.1016/j.vaccine.2013.05.018. - DOI - PubMed
    1. Plotkin S.A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 2010;17:1055–1065. doi: 10.1128/CVI.00131-10. - DOI - PMC - PubMed
    1. Merz B. HIV vaccine approved for clinical trials. J. Amer. Med. Assoc. 1987;258:1433–1434. doi: 10.1001/jama.1987.03400110013003. - DOI - PubMed
    1. Hu S.L., Abrams K., Barber G.N., Moran P., Zarling J.M., Langlois A.J., Kuller L., Morton W.R., Benveniste R.E. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science. 1992;255:456–459. - PubMed